Estimating the causal influence of body mass index on risk of Parkinson disease: A Mendelian randomisation study

被引:135
|
作者
Noyce, Alastair J. [1 ,2 ]
Kia, Demis A. [1 ]
Hemani, Gibran [3 ,4 ]
Nicolas, Aude [5 ]
Price, T. Ryan [5 ]
De Pablo-Fernandez, Eduardo [1 ]
Haycock, Philip C. [3 ,4 ]
Lewis, Patrick A. [1 ,6 ]
Foltynie, Thomas [7 ]
Smith, George Davey [3 ,4 ]
Schrag, Anette [8 ]
Lees, Andrew J. [1 ]
Hardy, John [1 ]
Singleton, Andrew [5 ]
Nalls, Mike A. [5 ,9 ]
Pearce, Neil [10 ]
Lawlor, Debbie A. [3 ,4 ]
Wood, Nicholas W. [1 ]
机构
[1] UCL, UCL Inst Neurol, Dept Mol Neurosci, London, England
[2] Queen Mary Univ London, Barts & London Sch Med & Dent, Ctr Neurosci & Trauma, London, England
[3] Univ Bristol, MRC Integrat Epidemiol Unit, Bristol, Avon, England
[4] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England
[5] NIA, Lab Neurogenet, NIH, Bethesda, MD 20892 USA
[6] Univ Reading, Sch Pharm, Reading, Berks, England
[7] UCL, UCL Inst Neurol, Sobell Dept Motor Neurosci & Movement Disorders, London, England
[8] UCL, Dept Clin Neurosci, UCL Inst Neurol, London, England
[9] Data Tecn Int, Glen Echo, MD USA
[10] London Sch Hyg & Trop Med, Dept Med Stat, London, England
基金
英国医学研究理事会;
关键词
METAANALYSIS; ASSOCIATION; INSTRUMENTS; OBESITY; BDNF; BIAS;
D O I
10.1371/journal.pmed.1002314
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Both positive and negative associations between higher body mass index (BMI) and Parkinson disease (PD) have been reported in observational studies, but it has been difficult to establish causality because of the possibility of residual confounding or reverse causation. To our knowledge, Mendelian randomisation (MR)-the use of genetic instrumental variables (IVs) to explore causal effects-has not previously been used to test the effect of BMI on PD. Methods and findings Two-sample MR was undertaken using genome-wide association (GWA) study data. The associations between the genetic instruments and BMI were obtained from the GIANT consortium and consisted of the per-allele difference in mean BMI for 77 independent variants that reached genome-wide significance. The per-allele difference in log-odds of PD for each of these variants was estimated from a recent meta-analysis, which included 13,708 cases of PD and 95,282 controls. The inverse-variance weighted method was used to estimate a pooled odds ratio (OR) for the effect of a 5-kg/m(2) higher BMI on PD. Evidence of directional pleiotropy averaged across all variants was sought using MR-Egger regression. Frailty simulations were used to assess whether causal associations were affected by mortality selection. A combined genetic IV expected to confer a lifetime exposure of 5-kg/m(2) higher BMI was associated with a lower risk of PD (OR 0.82, 95% CI 0.69-0.98). MR-Egger regression gave similar results, suggesting that directional pleiotropy was unlikely to be biasing the result (intercept 0.002; p = 0.654). However, the apparent protective influence of higher BMI could be at least partially induced by survival bias in the PD GWA study, as demonstrated by frailty simulations. Other important limitations of this application of MR include the inability to analyse non-linear associations, to undertake subgroup analyses, and to gain mechanistic insights. Conclusions In this large study using two-sample MR, we found that variants known to influence BMI had effects on PD in a manner consistent with higher BMI leading to lower risk of PD. The mechanism underlying this apparent protective effect warrants further study.
引用
收藏
页数:19
相关论文
共 50 条
  • [21] Mendelian randomisation analysis of clustered causal effects of body mass on cardiometabolic biomarkers
    Conde, Susana
    Xu, Xiaoguang
    Guo, Hui
    Perola, Markus
    Fazia, Teresa
    Bernardinelli, Luisa
    Berzuini, Carlo
    BMC BIOINFORMATICS, 2018, 19
  • [22] Mendelian randomisation analysis of clustered causal effects of body mass on cardiometabolic biomarkers
    Susana Conde
    Xiaoguang Xu
    Hui Guo
    Markus Perola
    Teresa Fazia
    Luisa Bernardinelli
    Carlo Berzuini
    BMC Bioinformatics, 19
  • [23] Body mass index and risk of inflammatory breast disease: a Mendelian randomization study
    Wei, Changlong
    Wang, Xiaofang
    Zeng, Jinsheng
    Zhang, Gongyin
    NUTRICION HOSPITALARIA, 2024, 41 (01)
  • [24] Body mass index, change in body mass index and risk of Parkinson's disease
    Lee, J.
    Kim, J. H.
    Cho, J. H.
    Kim, G. S.
    Lee, J. H.
    Lee, P. H.
    Sohn, Y. H.
    MOVEMENT DISORDERS, 2017, 32
  • [25] Body mass index may not have causal association with thyroid cancer risk: A Mendelian randomization study
    Kim, Jeongseon
    Lee, Soo Ji
    Nguyen, Quy N.
    Lee, Jeonghee
    Lee, Eun Kyung
    Hwangbo, Yul
    Sung, Joohon
    CANCER RESEARCH, 2018, 78 (13)
  • [26] Body mass index and inflammation in depression and treatment-resistant depression: a Mendelian randomisation study
    Karageorgiou, Vasilios
    Casanova, Francesco
    OLoughlin, Jessica
    Green, Harry
    McKinley, Trevelyan J.
    Bowden, Jack
    Tyrrell, Jessica
    BMC MEDICINE, 2023, 21 (01)
  • [27] Body mass index and inflammation in depression and treatment-resistant depression: a Mendelian randomisation study
    Vasilios Karageorgiou
    Francesco Casanova
    Jessica O’Loughlin
    Harry Green
    Trevelyan J. McKinley
    Jack Bowden
    Jessica Tyrrell
    BMC Medicine, 21
  • [28] Mendelian Randomisation Finds No Causal Association between Urate and Parkinson's Disease Progression
    Coneys, Rachel
    Storm, Catherine S.
    Kia, Demis A.
    Almramhi, Mona
    Wood, Nicholas W.
    MOVEMENT DISORDERS, 2021, 36 (09) : 2182 - 2187
  • [29] Causal relationship between body mass index and osteoporosis:A Mendelian randomization study
    任春蕊
    ChinaMedicalAbstracts(InternalMedicine), 2024, 41 (02) : 91
  • [30] Body mass index and risk of Parkinson's disease: A prospective cohort study
    Logroscino, Giancarlo
    Sesso, Howard D.
    Paffenbarger, Ralph S., Jr.
    Lee, I-Min
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2007, 166 (10) : 1186 - 1190